Clinical trial
G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients
NCT00499343 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00499343 |
|---|---|
| Title | G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients |
| Official title | A Randomized Study Comparing Chemotherapy Followed by G-CSF Alone Versus G-CSF Plus GM-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | Etoposide, G-CSF, GM-CSF, Isophosphamide, Rituximab, Apheresis |
| Enrollment | 84 |
| Start date | Jan 1, 2004 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jul 11, 2007 |
| Last update posted | Aug 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: